Jw Asset Management, Llc Buys 1,000 Shares of Establishment Labs Holdings Inc (NASDAQ:ESTA) Stock

Establishment Labs Holdings Inc (NASDAQ:ESTA) major shareholder Jw Asset Management, Llc acquired 1,000 shares of the business’s stock in a transaction dated Thursday, September 19th. The stock was purchased at an average price of $20.00 per share, with a total value of $20,000.00. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Jw Asset Management, Llc also recently made the following trade(s):

  • On Friday, August 23rd, Jw Asset Management, Llc purchased 1,000 shares of Establishment Labs stock. The shares were acquired at an average cost of $20.40 per share, for a total transaction of $20,400.00.
  • On Tuesday, August 20th, Jw Asset Management, Llc purchased 1,000 shares of Establishment Labs stock. The shares were acquired at an average cost of $20.00 per share, for a total transaction of $20,000.00.
  • On Friday, August 16th, Jw Asset Management, Llc purchased 2,000 shares of Establishment Labs stock. The shares were acquired at an average cost of $21.42 per share, for a total transaction of $42,840.00.
  • On Monday, August 12th, Jw Asset Management, Llc bought 3,000 shares of Establishment Labs stock. The stock was purchased at an average cost of $22.15 per share, for a total transaction of $66,450.00.
  • On Wednesday, July 31st, Jw Asset Management, Llc bought 1,500 shares of Establishment Labs stock. The stock was purchased at an average cost of $25.31 per share, for a total transaction of $37,965.00.
  • On Monday, July 29th, Jw Asset Management, Llc bought 2,500 shares of Establishment Labs stock. The stock was purchased at an average cost of $25.58 per share, for a total transaction of $63,950.00.

ESTA opened at $18.56 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.70 and a current ratio of 3.94. The stock has a market capitalization of $380.48 million, a P/E ratio of -16.57 and a beta of 0.27. The company’s 50-day simple moving average is $20.39 and its two-hundred day simple moving average is $23.16. Establishment Labs Holdings Inc has a 52-week low of $16.55 and a 52-week high of $30.06.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Tuesday, August 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.52) by $0.08. Establishment Labs had a negative net margin of 38.63% and a negative return on equity of 60.43%. The business had revenue of $21.68 million for the quarter, compared to analysts’ expectations of $20.10 million. Research analysts forecast that Establishment Labs Holdings Inc will post -1.95 EPS for the current fiscal year.

ESTA has been the topic of a number of research analyst reports. Stephens initiated coverage on shares of Establishment Labs in a research report on Thursday, June 6th. They set an “overweight” rating and a $37.00 price objective on the stock. Zacks Investment Research cut shares of Establishment Labs from a “hold” rating to a “sell” rating in a report on Friday, August 16th. ValuEngine upgraded shares of Establishment Labs from a “hold” rating to a “buy” rating in a report on Monday, July 29th. Finally, Wells Fargo & Co set a $29.00 target price on shares of Establishment Labs and gave the company a “buy” rating in a report on Friday, July 12th. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. Establishment Labs currently has a consensus rating of “Buy” and an average price target of $35.33.

Institutional investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC boosted its stake in Establishment Labs by 257.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,350 shares of the company’s stock worth $30,000 after purchasing an additional 972 shares during the period. JPMorgan Chase & Co. boosted its stake in Establishment Labs by 96.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 13,014 shares of the company’s stock worth $273,000 after purchasing an additional 6,386 shares during the period. Vanguard Group Inc. bought a new position in Establishment Labs in the 2nd quarter worth approximately $349,000. BBR Partners LLC bought a new position in Establishment Labs in the 2nd quarter worth approximately $445,000. Finally, Wells Fargo & Company MN bought a new position in shares of Establishment Labs during the 2nd quarter valued at approximately $479,000. 42.92% of the stock is owned by institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue.

Featured Article: Treasury Bonds

Insider Buying and Selling by Quarter for Establishment Labs (NASDAQ:ESTA)

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply